federal_register: 2019-24916
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-24916 | Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention; Guidance for Industry; Availability | Notice | The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention." The purpose of this guidance is to assist sponsors in the clinical development of drugs for treating or preventing smallpox (variola virus) infection. This guidance finalizes the draft guidance of the same name issued on July 11, 2018. | 2019-11-18 | 2019 | 11 | https://www.federalregister.gov/documents/2019/11/18/2019-24916/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-guidance-for-industry | https://www.govinfo.gov/content/pkg/FR-2019-11-18/pdf/2019-24916.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention." The purpose of this guidance is to assist... |